Y10S 930/10
Factor viii, ahf
Official title: Factor VIII, AHF; related peptides
Y10S930/10 (Factor viii, ahf) appears on 45 US grants and 10 published applications in this corpus.
Search patents in Y10S- Granted patents
- 45
- Published applications
- 10
- Assignees
- 21
- Inventors
- 49
- Latest grant
- 17 Oct 2006
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1987 | 2 | 0 |
| 1988 | 3 | 0 |
| 1989 | 3 | 0 |
| 1990 | 1 | 0 |
| 1991 | 0 | 0 |
| 1992 | 0 | 0 |
| 1993 | 2 | 0 |
| 1994 | 2 | 0 |
| 1995 | 1 | 0 |
| 1996 | 2 | 0 |
| 1997 | 11 | 0 |
| 1998 | 2 | 0 |
| 1999 | 4 | 0 |
| 2000 | 3 | 0 |
| 2001 | 1 | 1 |
| 2002 | 2 | 1 |
| 2003 | 1 | 2 |
| 2004 | 2 | 2 |
| 2005 | 0 | 2 |
| 2006 | 3 | 0 |
| 2007 | 0 | 0 |
| 2008 | 0 | 0 |
| 2009 | 0 | 0 |
| 2010 | 0 | 0 |
| 2011 | 0 | 0 |
| 2012 | 0 | 0 |
| 2013 | 0 | 0 |
| 2014 | 0 | 0 |
| 2015 | 0 | 0 |
| 2016 | 0 | 0 |
| 2017 | 0 | 0 |
| 2018 | 0 | 0 |
| 2019 | 0 | 0 |
| 2020 | 0 | 0 |
| 2021 | 0 | 1 |
| 2022 | 0 | 0 |
| 2023 | 0 | 0 |
| 2024 | 0 | 1 |
By publication year. Applications have been published since 2001.
Recent patents
- Modified factor VIII17 Oct 2006US 7,122,634 B2Emory University
- Factor VIII polypeptide9 May 2006US 7,041,635 B2In2Gen Co., Ltd.
- Modified factor VIII14 Mar 2006US 7,012,132 B2Emory University
- Modified factor VIII3 Aug 2004US 6,770,744 B2Emory University
- Glycosylated, low antigenicity low immunogenicity factor VIII6 Jul 2004US 6,759,216 B1Emory University
- Modified antibody-albumin nanoparticle complexes for cancer treatment22 Feb 2024US 2024/0058296 A1Mayo Foundation for Medical Education and Research
- Modified antibody-albumin nanoparticle complexes for cancer treatment2 Sep 2021US 2021/0267930 A1Mayo Foundation for Medical Education and Research
- Modified factor VIII14 Apr 2005US 2005/0079584 A1Emory University
- Glycosylated, low antigenicity, low immunogenicity factor VIII13 Jan 2005US 2005/0009148 A1
- Factor VIII polypeptide29 Jul 2004US 2004/0147436 A1In2Gen Co., Ltd.
Most cited
By later US patents
- Preparation of functional human factor VIII in mammalian cells using methotrexate based selection276US 4,965,199 AGenentech, Inc. · 1990
- Human factor VIII:C gene and recombinant methods for production226US 4,757,006 AGenetics Institute, Inc. · 1988
- Novel procoagulant proteins157US 4,868,112 AGenetics Institute, Inc. · 1989
- Modified factor VIII94US 6,458,563 B1Emory University · 2002
- Factor VIII polypeptide85US 7,041,635 B2In2Gen Co., Ltd. · 2006